SCHEMBL94997

SCHEMBL94997

[CH2]c1ccc(NS(=O)(=O)c2c(C)nn(C)c2Cl)cc1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SGK1 O00141 4/20 0.53
MCL1 Q07820 1/20 0.52
ACLY P53396 2/20 0.48
MAPT P10636 1/20 0.45
CCR2 P41597 1/20 0.44
TSHR P16473 2/20 0.44
NMT1 P30419 1/20 0.43
PCK1 P35558 2/20 0.41
HTR6 P50406 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
FPR2 P25090 1/20 0.39
PROKR1 Q8TCW9 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
GFER P55789 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27621550 0.77 ALDH1A1 (0.60) SGK1MCL1ACLYTDP1POLB
SCHEMBL14721124 0.74 MCL1 (0.47) SGK1MCL1ACLYMAPTCCR2
SCHEMBL4615405 0.74 SGK1 (0.48) SGK1MCL1ACLYMAPTCCR2
SCHEMBL96179 0.72 ATM (0.55) MAPTTSHRPOLBGAAGFER
SCHEMBL15882311 0.72 ACLY (0.50) SGK1MCL1ACLYCCR2TSHR
SCHEMBL5653065 0.72 MEN1 (0.49) SGK1MCL1ACLYMAPTCCR2
SCHEMBL6097407 0.72 MCL1 (0.45) SGK1MCL1ACLYCCR2TSHR
SCHEMBL94670 0.71 GAA (0.71) MAPTTSHRPOLBGAAGFER
SCHEMBL2303572 0.71 RXFP1 (0.62) SGK1MCL1ACLYCCR2L3MBTL1
SCHEMBL4829257 0.70 SGK1 (0.45) SGK1MCL1ACLYMAPTCCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
CN-101489555-A Nf-kappa OTSUKA PHARMA CO LTD (JP) 2009-07-22 CN disclosed
EP-2043644-A1 NF- B INHIBITOR Otsuka Pharmaceutical Co., Ltd. (JP) 2009-04-08 EP disclosed
WO-2008010601-A1 NF- ϰB INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-01-24 WO disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB SGK1 494/4885MCL1 992/4885ACLY 4141/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 SGK1 845/4885MCL1 3284/4885ACLY 3499/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 SGK1 845/4885MCL1 3284/4885ACLY 3499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.